Zenas Biopharma Is A Clinical Stagebiopharmaceutical Company Based In Walthammassachusettsit Is Dedicated To Developing And Commercializing Therapies For Autoimmunediseasesthecompany Is Listed On Thenasdaq Under Theticker Symbol Zbiozenas Biopharma Focuses On Addressing Significant Unmet Patient Needs Through Innovativetreatments That Aim To Improvethelives Of Individuals Affected By Autoimmuneconditions Thecompany S Primary Product Is Obexelimaba Bifunctional Monoclonal Antibody Targeting Cd19 And Fci Riib To Suppress B Cell Activityobexelimab Is Currently Undergoing Several Clinical Trialsincluding Thephase Indigo Trial For Immunoglobulin G4 Related Diseasethephase2 Moonstonetrial For Relapsing Multiplesclerosisand Theupcoming Phase2 Sunstonetrial For Systemic Lupus Erythematosuszenas Biopharma Also Engages In Clinical Trials Managementpatient Supportand Research And Development To Advanceits Pipelineand Enhancepatient Care
